Neoadjuvant sintilimab combined with gemcitabine and cisplatin (GP) for muscle-invasive bladder cancer (MIBC) patients followed by selective bladder sparing surgery

被引：0
|
作者：
Tong, Z. [1 ]
Fu, G. [2 ]
Zhou, F. [2 ]
Liu, X. [3 ]
Xue, X. [4 ]
Zhang, H. [1 ]
Wang, Y. [2 ]
Zhu, X. [1 ]
Gao, Y. [1 ]
Liu, L. [1 ]
Bao, X. [1 ]
Zheng, Y. [1 ]
Fang, W. [1 ]
Zhao, P. [1 ]
Jin, B. [2 ]
机构：
[1] Zhejiang Univ, Dept Med Oncol, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Urol, Hangzhou, Peoples R China
[3] Zhejiang Univ, Dept Pathol, Affiliated Hosp 1, Hangzhou, Peoples R China
[4] Zhejiang Univ, Dept Radiol, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2375P
引用
收藏
页码：S1210 / S1210
页数：1
相关论文
共 50 条
  • [1] A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC)
    Xu, Abai
    Xu, Peng
    Chen, Chunxiao
    Liu, Zhe
    Jiang, Ning
    Bi, Enguang
    Cao, Manming
    Chen, BinShen
    Liu, Chunxiao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [3] Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
    Sung, Hyun Hwan
    Kim, Hana
    Kim, Ryul
    Kim, Chan Kyo
    Kwon, Ghee Young
    Park, Won
    Song, Wan
    Jeong, Byong Chang
    Park, Se Hoon
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (02) : 168 - 174
  • [4] Bladder Preservation by Neoadjuvant Chemotherapy followed by Concurrent Chemoradiotherapy with Gemcitabine in Muscle Invasive Bladder Cancer (MIBC)
    Anandadas, C.
    Thompson, C.
    Sanderson, B.
    Lyons, J.
    Stratford, J.
    Logue, J. P.
    [J]. CLINICAL ONCOLOGY, 2013, 25 (04) : E69 - E69
  • [5] Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
    Narayan, Vivek
    Mamtani, Ronac
    Keefe, Stephen
    Guzzo, Thomas
    Malkowicz, S. Bruce
    Vaughn, David J.
    [J]. CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1084 - 1091
  • [6] BLADDER-SPARING SURGERY (BSS) FOR MUSCLE-INVASIVE BLADDER CANCER (MIBC) AFTER COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY (NAC)
    Herr, Harry
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1084 - E1084
  • [7] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
  • [8] Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Balar, Arjun Vasant
    Iyer, Gopa
    Apolo, Andrea Borghese
    Regazzi, Ashley Marie
    Garcia-Grossman, Ilana Rebecca
    Pendse, Deepa
    Ostrovnaya, Irina
    Chou, Joanne F.
    Bochner, Bernard
    Dalbagni, Guido
    Herr, Harry W.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Biomarker Exploration for neoadjuvant chemotherapy with gemcitabine combined with cisplatin in muscle-invasive bladder cancer.
    Wang, Kun
    Chen, Xusheng
    Zhang, Zhenting
    Hu, Hailong
    Zhang, Aili
    Wang, Xin
    Chen, Lijun
    Liu, Zhizhong
    Yue, Changjiu
    Zhang, Xueying
    Zhang, Menghuan
    Yao, Xin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16556 - E16556
  • [10] Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update
    Gupta, Shilpa
    Weight, Christopher J.
    Agarwal, Neeraj
    Gupta, Sumati
    Konety, Badrinath
    Gibb, Ewan
    Davicioni, Elai
    Thyagarajan, Bharat
    Sonpavde, Guru
    [J]. CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
12345